Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02NTS
|
||||
Former ID |
DIB000312
|
||||
Drug Name |
JNJ-39393406
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cognitive disorders [ICD9: 290-294, 294.0, 780.09, 780.9, 780.93; ICD10:F01-F07, F04, F05, R41.3] | Phase 1 | [523838] | ||
Company |
Janssen Pharmaceutica NV
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H18F2N6O3
|
||||
Canonical SMILES |
CN(C)C(=O)CCN1C(=NC(=N1)NC2=CC3=C(C=C2)OC(O3)(F)F)C4=CC<br />=NC=C4
|
||||
InChI |
1S/C19H18F2N6O3/c1-26(2)16(28)7-10-27-17(12-5-8-22-9-6-12)24-18(25-27)23-13-3-4-14-15(11-13)30-19(20,21)29-14/h3-6,8-9,11H,7,10H2,1-2H3,(H,23,25)
|
||||
InChIKey |
IURMHZBQEYNQOH-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Neuronal acetylcholine receptor protein, alpha-7 chain | Target Info | Modulator | [531960] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.